The Best Bike Helmets for Protecting Your Noggin
Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Much like the Persist, the Giro Aeries Spherical takes the MIPS system a bit further, combining it with the brand's new Spherical technology, which is a ball-and-socket design system that redirects energy away from the brain during certain impacts. Basically, think of the helmet as two attached pieces, where the upper dome it able to lightly rotate over the lower part—the part that's attached to your head—giving you another level of protection. It also boasts Giro's new proprietary DryCore system, which redirects sweat away from the forehead (and therefore out of your eyes), toward your temples, where it evaporates more quickly. Over the same route I tested the other road helmets, I marveled at the Aeries' barely-there light weight. Weighing in at 275 grams, it felt like I was riding sans helmet. Thanks to the helmet's massive and numerous vents paired with Giro's DryCore system, my head never came close to overheating on another hot, sunny, humid day. Like the Kask, the sticker price might be way too high for many. However, if helmets are something you don't mind dropping coin on, the Aeries is worth every single penny. Specs Weight: 275 g (medium) | Size Range: S, M, L | MIPS? Yes
Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani According to megabrand Specialized, their new Propero 4 combines their most aero road helmets with their most ventilated ones. Now, I don't have access to a wind tunnel, so I can't confirm Specialized's claims that the Propero 4 is fifteen seconds faster over 40 kilometers than one of its predecessors, the S-Works Prevail 3. But I can say that the Propero 4 provided an easy and comfortable fit, with a simple adjustment system that allowed me to find a great fit in a matter of seconds. It also boasts, in addition to three massive front vents, two smaller vents that are dedicated for sunglasses storage. In other words, an exacting place to stick the arms of your riding shades when the sun dips behind the clouds. And, as looking cool is paramount, I'm happy to report that the test model I tried came in a super interesting blend of matte and gloss white that was only noticeable when viewed up close, which is always a factor in racking up cool points. Specs Weight: 295 g (medium) | Size Range: S, M, L | MIPS? Yes
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
20-05-2025
- Business Wire
Persist® Biochar and Persist® PAF Bioliquid Earn California OIM Certification
CAMARILLO, Calif.--(BUSINESS WIRE)-- VGrid Energy Systems, a California-based renewable energy company and maker of Persist ® Plant and Soil Enhancers, announced today that its two flagship products—Persist® Biochar and Persist® PAF Bioliquid—have both been certified as Organic Input Materials (OIM) by the California Department of Food and Agriculture (CDFA). This certification confirms that both products meet the rigorous standards required for use in certified organic farming and food production. Persist® PAF is a liquid plant and soil enhancer containing organic acids, phenols, and beneficial biomolecules that enhance flowering, yield, and overall soil productivity. Share The CDFA OIM certification is one of the country's most respected and stringent organic certifications. It verifies that agricultural inputs comply with California's environmental and organic production regulations and meet the National Organic Program (NOP) standards. In addition to this certification, both products remain OMRI Listed® for use in USDA certified organic production and are verified by the USDA's BioPreferred® Program as 100% biobased. 'Earning OIM certification is a major milestone for Persist and the growers we serve,' said Jeff Norton, Vice President of Business Development. 'These certifications reinforce our commitment to delivering effective and sustainable solutions that improve soil health, boost plant productivity, and support organic and regenerative agriculture.' Persist® Biochar is a carbon-rich soil amendment made from plant biomass, specifically pistachio shells. It improves soil structure, water retention, microbial activity, and long-term carbon sequestration. Persist® PAF is a liquid plant and soil enhancer containing organic acids, phenols, and beneficial biomolecules that enhance nutrient availability, plant stress response, and soil microbial activity. Both products are manufactured by VGrid Energy Systems using a proprietary biomass-to-energy technology that upcycles agricultural waste into high-value agricultural inputs and renewable electricity. Organic growers, distributors, and agricultural professionals can now incorporate Persist products with confidence, knowing they meet the highest standards for organic production. For more information or to request samples, visit or email info@ VGrid Energy Systems is a carbon-negative, renewable energy producer on a mission to reverse climate change. The company's innovative Bioserver® processes agricultural waste into 100% renewable electricity while creating valuable biochar and bioliquids that naturally improve crop yields and soil productivity. For more information, please visit and
WIRED
20-05-2025
- WIRED
The Best Bike Helmets for Protecting Your Noggin
Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Much like the Persist, the Giro Aeries Spherical takes the MIPS system a bit further, combining it with the brand's new Spherical technology, which is a ball-and-socket design system that redirects energy away from the brain during certain impacts. Basically, think of the helmet as two attached pieces, where the upper dome it able to lightly rotate over the lower part—the part that's attached to your head—giving you another level of protection. It also boasts Giro's new proprietary DryCore system, which redirects sweat away from the forehead (and therefore out of your eyes), toward your temples, where it evaporates more quickly. Over the same route I tested the other road helmets, I marveled at the Aeries' barely-there light weight. Weighing in at 275 grams, it felt like I was riding sans helmet. Thanks to the helmet's massive and numerous vents paired with Giro's DryCore system, my head never came close to overheating on another hot, sunny, humid day. Like the Kask, the sticker price might be way too high for many. However, if helmets are something you don't mind dropping coin on, the Aeries is worth every single penny. Specs Weight: 275 g (medium) | Size Range: S, M, L | MIPS? Yes Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani Photograph: Michael Venutolo-Mantovani According to megabrand Specialized, their new Propero 4 combines their most aero road helmets with their most ventilated ones. Now, I don't have access to a wind tunnel, so I can't confirm Specialized's claims that the Propero 4 is fifteen seconds faster over 40 kilometers than one of its predecessors, the S-Works Prevail 3. But I can say that the Propero 4 provided an easy and comfortable fit, with a simple adjustment system that allowed me to find a great fit in a matter of seconds. It also boasts, in addition to three massive front vents, two smaller vents that are dedicated for sunglasses storage. In other words, an exacting place to stick the arms of your riding shades when the sun dips behind the clouds. And, as looking cool is paramount, I'm happy to report that the test model I tried came in a super interesting blend of matte and gloss white that was only noticeable when viewed up close, which is always a factor in racking up cool points. Specs Weight: 295 g (medium) | Size Range: S, M, L | MIPS? Yes
Yahoo
19-05-2025
- Yahoo
Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding
AI-driven robotics platform reduces drug formulation development time from years to months SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today announced the launch of its innovative Cloud Lab platform following the successful closure of an oversubscribed $12 million Series A financing round. The new platform allows pharmaceutical companies to develop formulations using Persist AI's state-of-the-art robotic laboratory facilities through a website, dramatically accelerating drug development timelines while using a fraction of the materials required by traditional methods. The funding round was led by Spero Ventures with participation from MBX Capital, Shimadzu Future Innovation Fund managed by Global Brain Corporation, Eli Lilly & Company, SignalFire, Ford Street Capital, Purdue Ventures, Good AI Capital, Cartography Capital, Asymmetry Ventures, and existing investors 2048 Ventures, Innospark, and YCombinator. "Every drug that reaches the market depends on an optimal formulation. While the industry has heavily invested in AI and predictive tools across the drug development pipeline, formulation has remained a blind spot—until now." said Sara Eshelman, General Partner at Spero Ventures. "Persist dramatically reduces both the time and cost at every stage of development, ultimately lowering the hurdle for investment in next-generation therapeutics like long-acting injectables." Predict the ideal formulation with Persist's AI models Persist AI's technology enables pharmaceutical companies to predict formulation recipes and performance using sophisticated AI models and subsequently build and test them using robotic systems. In a recent project with a major pharmaceutical client, Persist AI demonstrated the power of its platform by identifying an optimal long-acting injectable formulation in just two months—a process that traditionally takes a year or longer. By rapidly building and testing 700 formulations in two months, compared to the industry standard of 10-15 formulations per month, Persist AI accelerates a critical phase in bringing new drugs to market. "AI is enabling pharma to discover new molecules faster than ever. But a molecule that has poor shelf life cannot become a drug product that sits on a shelf. Our mission is to convert these novel molecules into products, such as tablets and injections that patients can use," said Karthik Raman, CEO of Persist. "If you can find a new drug molecule, you can predict its formulation and use our robotic platform to build and test it in the real world." Persist Cloud Lab – A Robotic Lab to Build and Test Formulations Remotely Once the AI models predict a set of formulations, Persist's Cloud Lab enables pharmaceutical scientists to test the formulation by remotely controlling the robotic lab. With a combination of miniaturization and seamless automation of formulation testing instruments, Persist's technology leads to an unprecedented speed advantage in drug development. Traditional testing instruments often require large volumes of liquid and significant amounts of formulation material per test. As an example, a standard dissolution testing apparatus requires 1000 mL of liquid and several grams of formulation. In contrast, Persist's miniaturized systems can deliver results with just 1 mL of liquid and a few milligrams of material. This breakthrough not only conserves valuable drugs but also enables higher throughput testing. "Persist AI has assembled a talented chemistry, engineering, and software team that develops exceptional automated solutions for formulation development workflows," said Chris Shelner, COO of Persist. "We continue to improve our automation in addition to expanding capacity and workflow scope." Through the newly launched Cloud Lab, pharmaceutical companies worldwide can now remotely build and test formulations on Persist's advanced robotic facilities to develop: Long acting injectables Tablets and capsules Topical formulations for cosmetics and pharmaceuticals Injectable formulations The platform supports a wide range of modalities including peptides, small molecules, antibodies, and anti-sense oligonucleotides, currently serving multiple top 10 pharmaceutical clients and several smaller biotechs developing next-generation treatments for chronic diseases. Series A Funding to Accelerate Growth and Innovation The $12 million in Series A funding will support several key initiatives. Persist will build a GMP manufacturing system for long acting injectables, in collaboration with Nivagen Pharmaceuticals in Sacramento, CA. Funds will be used to expand the robotic lab and build comprehensive data sets that train the company's AI models. Additionally, the team will expand the capacity and range of formulations the AI models and robotic lab can predict, build, and test. Persist is actively seeking pharmaceutical partners for co-development of drug products, robotic platforms, and AI training data sets. To learn more about Persist AI's Cloud Lab platform and request access, visit Pharmaceutical companies interested in partnership opportunities are encouraged to contact Karthik Raman via his email below or through the website. About Persist AI Persist AI is revolutionizing pharmaceutical development through AI-driven robotics for formulation development and CMC. By combining predictive AI models with automated robotic systems, Persist AI enables pharmaceutical companies to develop drug formulations in a fraction of the time and cost of traditional approaches. The company works across multiple modalities and formulation types to accelerate bringing novel therapeutics to patients. Persist AI is a Y Combinator-backed company, having graduated from the prestigious startup accelerator in 2023. About the Leadership Team Karthik Raman, CEO and Co-founder of Persist, brings extensive expertise in formulation development. Prior to founding Persist, Raman was part of the automation team at Zymergen, developing the next generation robotic factory for synthetic biology. Co-founder Christopher Shelner serves as Chief Operating Officer, with significant expertise in automation design, operations, and deployment from his work at industry leaders including Northrop Grumman and Apple. View original content to download multimedia: SOURCE Persist AI Formulations Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
